NIH Histology Services Proposal LPTA Compliance Gap Analysis

INST-2.1

Technical approach must include workflow descriptions, QC measures, throughput capabilities for trimming/embedding, H&E, IHC, and scanning/storage/access

Extensive workflow + QC + throughput/risk management sections

Compliant

Low

INST-2.2

Explain meeting 5–10 business day turnaround and pickup/delivery logistics

Section 3 Turnaround Time & Logistics; detailed courier/chain-of-custody

Compliant

Low

INST-2.3

Document storage capacity (≥67 TB), user access controls (≥3), annotation/snapshots/raw download, 12-month retention

Section 4 Digital Platform Description includes all items

Compliant

Low

INST-2.4

Detail procedures to provide all deliverables (blocks, slides, images, platform access, report)

Section 5 Deliverables Plan covers all

Compliant

Low

INST-2.5

Must include names & qualifications of personnel; identification of PM

States PM and roles; but defers names to final submission

Partially Compliant

High (could be deemed missing required information)

INST-2.6

Describe facilities, equipment, data storage and IT security measures

Section 7 provides detail; security measures described generally

Partially Compliant

Medium (add explicit encryption at rest / security controls to reinforce 'secure')

PP-01

Up to three past performance examples; POCs for verification; no negative history for pass

States “will provide up to three… will provide POC details… confirm no negative history” but does not list actual examples

Partially Compliant

Medium (if solicitation expects actual examples in submission, not a promise)

PRICE-01

Provide complete price breakdown; separate file/section; match technical approach

Provides narrative intent to submit separate labeled price proposal with breakdown categories; no actual pricing included in provided text

Partially Compliant

Medium (depends on whether this excerpt is the complete proposal set)

SOW-POP-01

Period of Performance: June 1, 2026 – May 31, 2027

States PoP: “period of performance June 1, 2026 through May 31, 2027.”

Covered

None

Pass support

SOW-GEN-01

Contractor furnishes all necessary services, qualified personnel, material, equipment, facilities not provided by Government

States: “furnish all personnel, routine consumables, equipment, and facilities…” and notes Government-furnished antibodies.

Covered

None

Pass support

SOW-GOV-01

Government provides 58 brain sample cases and required antibodies

Acknowledges Government-provided manifest and “Government-furnished… antibodies.”

Covered

None

Pass support

SOW-SPEC-01

58 large, multiple piece brain samples

Repeated multiple times (58 cases/samples)

Covered

None

Pass support

SOW-SPEC-02

Trimming, cassette printing, processing and wet embedding into paraffin for 16 blocks per sample

Detailed workflow; “sixteen (16) blocks per sample”; trimming plan; barcode cassettes; processing; wet embedding.

Covered

None

Pass support

SOW-SPEC-03

Routine H&E morphology staining for 16 blocks per sample

Detailed H&E staining; QC; recut/restain; explicitly “H&E slides for each of the sixteen (16) blocks per sample.”

Covered

None

Pass support

SOW-SPEC-04

Chromogenic immunostaining on 30 slides per sample using a biotin-free assay

Explicit: “thirty (30) slides per sample using a biotin-free assay”; polymer-based detection; controls/QC.

Covered

None

Pass support

SOW-SPEC-05

Use specified antibodies: phospho-TDP-43 clone 11-9; phospho-Ser129 alpha-synuclein; beta-amyloid; phospho-Tau AT8 (Invitrogen) (SOW text includes 'AT8, Biotin')

Lists all four antibodies and vendors; states “biotin-free assay” and polymer detection.

Partially Covered

Text discrepancy: solicitation lists “Phospho-TDP-42” (likely typo) and “AT8, Biotin, Invitrogen” while SOW also requires biotin-free assay. Proposal should explicitly state it will follow SOW-listed antibody specifications exactly (including any 'biotin' labeling if that refers to antibody format) and reconcile naming (TDP-43 vs TDP-42).

Potential Fail if evaluator treats mismatch as noncompliance

SOW-SPEC-06

Digital 40× scanning and preservation of images for 12 months on contractor’s platform

Explicit: “true 40×”; “preserved for twelve (12) months on our platform.”

Covered

None

Pass support

SOW-PLAT-01

Platform includes minimum 67 TB secure storage

Explicit: “minimum of sixty-seven terabytes (67 TB) dedicated…”

Covered

None

Pass support

SOW-PLAT-02

3 users with ability to view, annotate, snapshot, and download raw files

Explicit: “minimum of three (3) Government users”; “three named user accounts”; view/annotate/snapshot/download raw files.

Covered

None

Pass support

SOW-PLAT-03

Secure storage/user access (security implied by 'secure storage')

Mentions encrypted transmission, secure authentication, controlled admin access, audit logs, backups, vulnerability management.

Partially Covered

No explicit commitment to encryption at rest, FedRAMP/HIPAA alignment, or specific security standard (not required by SOW, but 'secure' can be interpreted variably). Consider stating encryption at rest and access logging retention.

Medium risk of questions; not usually pass/fail unless evaluator interprets 'secure' strictly

SOW-SPEC-07

Provide all slides related to the 58 samples

States: “provide all stained slides… all slides related”; return physical slides; inventory reconciliation.

Covered

None

Pass support

SOW-SPEC-08

Provide neuropathology services within 5–10 business days after receiving samples

Explicit: “complete … within five (5) to ten (10) business days after receiving samples.”

Covered

None

Pass support

SOW-SPEC-09

Pickup and delivery from NIH main campus in Bethesda, Maryland

Explicit logistics section; trained couriers; pickup/delivery to/from NIH Bethesda.

Covered

None

Pass support

DELIV-01

Deliver trimming/cassette printing/wet embedding on 16 blocks for 58 samples

Deliverables plan confirms 16 blocks per sample for 58.

Covered

None

Pass support

DELIV-02

Deliver immunostaining on 30 slides for each of the 58 samples

Deliverables plan confirms 30 IHC slides per sample.

Covered

None

Pass support

DELIV-03

Provide 40× scanning and image preservation for all images related to the 58 samples

States scanning at 40× and 12-month preservation; indicates all required images.

Partially Covered

SOW says “all images related to the 58 samples.” Proposal should explicitly commit that every required H&E and all 30 IHC slides per sample will be scanned at 40× (not just “all slides included in scanning scope”).

Potential Fail if 'scope' wording is interpreted as carving out exclusions

DELIV-04

Provide platform for viewing, annotating, and downloading raw files

Explicit platform capabilities included.

Covered

None

Pass support

DELIV-05

Provide slides used for analysis

Explicitly provides/returns slides and inventory documentation.

Covered

None

Pass support

REPORT-01

One-time report documenting sample processing procedures

Explicit: “one-time report documenting sample processing procedures.” Defines contents and format.

Covered

None

Pass support

OTHER-TRAVEL-01

Principal place of performance is contractor’s work site

States pickup/delivery; implies work at contractor lab; does not explicitly restate POP location.

Partially Covered

Add a sentence explicitly acknowledging principal place of performance is contractor site (administrative but tied to 'other considerations').

Low

KEY-01

Dedicated project manager to Government as POC

Explicit: dedicated Project Manager, single POC, coordinates logistics, updates, platform provisioning.

Covered

None

Pass support

LPTA-1.1-01

Demonstrate capability for all tasks at required volumes with specified assays

Detailed end-to-end workflow; QC; throughput; volumes.

Covered

None

Pass support

LPTA-1.2-01

All platform requirements met without exceptions (40×, 12 months, ≥67 TB, 3 users with permissions)

Explicit commitments present.

Covered

None

Pass support

LPTA-1.3-01

Turnaround 5–10 business days AND pickup/delivery logistics

Explicit commitments and explanation.

Covered

None

Pass support

LPTA-1.4-01

Commit to all deliverables with no exceptions

Provides blocks, stained slides, scanned images, platform access, report.

Partially Covered

Tighten language to avoid ambiguity: remove/clarify “slides included in the scanning scope”; explicitly state all required slides will be scanned and posted.

Medium (avoidable ambiguity)

LPTA-1.5-01

Identify adequately trained personnel + dedicated PM; proposal must include names & qualifications

States roles, training, oversight; says names will be identified in final submission; resumes will be provided.

Partially Covered

Solicitation requires names & qualifications in the proposal. Replace future-tense (“will be identified”) with actual names/titles and include summarized qualifications/resumes now.

High (common LPTA fail point)

LPTA-1.6-01

Facilities & equipment sufficient; secure IT infrastructure

Describes lab areas, instruments, maintenance, contingency capacity, IT safeguards.

Covered

None

Pass support

End-to-end histology workflow

Trimming→embedding (16 blocks/sample), H&E (16), IHC (30)

Stepwise workflow with LIS, barcode traceability, QC gates, recut/restain, run controls

Strong

Volume and throughput readiness

Handle 58 large multi-piece samples within 5–10 days

Parallelization, reserved instrument time, cross-trained staff, batch sizing, same-day rework paths

Strong

Digital imaging & platform

40× scanning, 12-month retention, ≥67 TB, 3 users with view/annotate/snapshot/download

Explicit platform features + audit logs + user support + capacity headroom

Strong

Logistics

Pickup/delivery NIH Bethesda; chain-of-custody

Courier plan, documented handoffs, sealed containment, inventory reconciliation

Strong

Reporting

One-time processing procedures report

Report scope, format, reproducibility/auditability stated

Strong

GAP-01

Personnel identification

Defers key personnel names to “final proposal submission”; provides roles but not names/quals in-text

2.5 Staffing & Key Personnel (names & qualifications required); LPTA 1.5 pass criteria

High × High

Evaluators may mark as Technically Unacceptable for missing required information even if capability is described.

GAP-02

Antibody naming/spec mismatch

Proposal lists phospho-TDP-43; SOW bullet says “Phospho-TDP-42” (likely typo) and “AT8, Biotin, Invitrogen” while also requiring biotin-free assay

SOW Specific Requirements; LPTA 1.1

Medium × High

Any perceived deviation from specified reagents/assay format can trigger automatic fail; needs explicit statement to comply with SOW list as written and seek COR clarification if inconsistent.

GAP-03

Scanning scope wording ambiguity

States “scanned images at 40× for all slides included in the scanning scope”

Deliverables + LPTA 1.4; Imaging requirements

Medium × High

The phrase can be read as reserving the right to exclude some slides from scanning, conflicting with “all images related to the 58 samples.”

GAP-04

Past performance content completeness

Provides a plan to submit up to 3 examples, but no actual projects listed in the provided text

Past Performance Submission instructions

Medium × Medium

Could be considered incomplete if the submission must include the actual examples now.

GAP-05

Security specificity for 'secure' platform/storage

Mentions encryption in transit, auth, audit logs, vulnerability mgmt; not explicit on encryption at rest, access review, incident response, or hosting compliance

Platform requirements use “secure storage”; Instructions ask for IT security measures

Low × Medium

Not explicitly required, but strengthening reduces evaluator questions and supports 'secure' interpretation.

R-01

Technical Unacceptability due to missing named Key Personnel

Names/resumes not present; future-tense commitment

High

High

Insert named PM and key staff (or at least named Key Personnel positions) and attach concise qualification summaries/resumes; explicitly map each to tasks (histology/IHC/scanning/IT).

R-02

Technical Unacceptability due to perceived deviation from required antibody specifications

TDP-43 vs TDP-42 mismatch; 'AT8, Biotin' phrase in SOW vs biotin-free assay requirement

Medium

High

Add explicit compliance statement: will use the Government-furnished antibodies exactly as provided/identified in the SOW and perform biotin-free detection chemistry; request/confirm clarification through Q&A if needed; mirror SOW nomenclature in a compliance table.

R-03

Evaluator interprets scanning deliverable as partial/excluded

“slides included in scanning scope” wording

Medium

High

Replace with unequivocal commitment to scan all required H&E and all 30 IHC slides per sample at 40× and preserve for 12 months; define any exceptions only if SOW allows (it does not).

R-04

Past performance rated unacceptable/incomplete for missing examples/POCs

No actual examples included in excerpt

Medium

Medium

Provide 1–3 specific past performance narratives with volumes, markers, turnaround, platform/storage, and full POC details; explicitly state no negative relevant history.

R-05

Platform security questioned leading to clarifications or concern

Security described generally; 'secure storage' not fully substantiated

Low

Medium

Add explicit controls: encryption at rest, MFA for admin access, RBAC detail, audit log retention, backup frequency, incident handling contact/process (as appropriate), and data deletion/export approach after 12 months.

REC-01

Add a one-page 'Compliance Matrix' section that verbatim lists each SOW/LPTA requirement (volumes, turnaround, pickup/delivery, platform features, deliverables, report) with a clear 'Comply' statement and proposal section cross-reference.

All SOW bullets; LPTA 1.1–1.6; Instructions 2.1–2.6

Reduces evaluator effort and eliminates ambiguity in LPTA pass/fail determinations.

REC-02

Replace all future-tense staffing language with actual names, roles, and concise qualifications; explicitly identify the dedicated Project Manager by name as Key Personnel and include resumes/qualification summaries.

LPTA 1.5; Instructions 2.5; Key Personnel requirement

Closes a high-probability fail condition for missing required information.

REC-03

Resolve antibody/spec discrepancies by mirroring the SOW antibody text exactly in the proposal and adding a clarifying statement that you will stain using the Government-furnished antibodies provided; explicitly describe that detection chemistry is biotin-free even if an antibody is labeled 'biotin' (if applicable).

SOW-SPEC-04/05; LPTA 1.1

Prevents a technical acceptability failure due to apparent noncompliance or mismatch.

REC-04

Remove/modify 'slides included in the scanning scope' phrasing; explicitly commit to scanning at 40× all H&E slides (16 per sample) and all IHC slides (30 per sample), preserving all images for 12 months, and making them available to users.

DELIV-03; LPTA 1.4; LPTA 1.2

Eliminates a deliverables ambiguity that could be interpreted as an exception.

REC-05

Strengthen 'secure platform' description with explicit security controls (encryption at rest, RBAC detail, admin MFA, audit log retention, backup/DR statement). Keep it scoped to what you can commit to contractually.

Platform 'secure storage' language; Instructions 2.6

Improves credibility of 'secure' claim and reduces clarification risk.

REC-06

If the submitted package must include past performance now, replace the placeholder narrative with 1–3 actual references including volume metrics and platform/storage details; ensure POCs are complete.

Past Performance Submission

Prevents incompleteness findings and supports Pass/Fail past performance screening.

REC-07

Add explicit acknowledgment that the principal place of performance is the contractor’s work site, consistent with 'Other Considerations – Travel'.

Other Considerations – Travel

Removes minor compliance ambiguity and shows instruction adherence.